Pulmonary	B:C0034089
homograft	I:C0034089
stenosis	I:C0034089
in	O
the	O
Ross	O
procedure	I:C0087111
:	O
Incidence	O
,	O
clinical	O
impact	O
and	O
predictors	O
in	O
long	O
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
.	O

Pulmonary	O
homograft	I:C0034089
stenosis	I:C0034089
in	O
the	O
Ross	B:C0087111
procedure	I:C0087111
:	O
Incidence	O
,	O
clinical	O
impact	O
and	O
predictors	O
in	O
long	O
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
.	O

Pulmonary	O
homograft	I:C0034089
stenosis	I:C0034089
in	O
the	O
Ross	O
procedure	I:C0087111
:	O
Incidence	O
,	O
clinical	O
impact	O
and	O
predictors	O
in	O
long	B:C1517942
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
.	O

The	O
Ross	B:C0087111
procedure	I:C0087111
is	O
used	O
in	O
the	O
treatment	O
of	O
selected	O
patients	O
with	O
aortic	O
valve	I:C1260873
disease	I:C1260873
.	O

The	O
Ross	O
procedure	I:C0087111
is	O
used	O
in	O
the	O
treatment	B:C0087111
of	O
selected	O
patients	O
with	O
aortic	O
valve	I:C1260873
disease	I:C1260873
.	O

The	O
Ross	O
procedure	I:C0087111
is	O
used	O
in	O
the	O
treatment	O
of	O
selected	O
patients	O
with	O
aortic	B:C1260873
valve	I:C1260873
disease	I:C1260873
.	O

Pulmonary	B:C0034089
graft	I:C0034089
stenosis	I:C0034089
can	O
appear	O
in	O
the	O
long	O
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
after	O
the	O
Ross	O
intervention	I:C0184661
,	O
but	O
the	O
factors	O
involved	O
and	O
its	O
clinical	O
implications	O
are	O
not	O
fully	O
known	O
.	O

Pulmonary	O
graft	I:C0034089
stenosis	I:C0034089
can	O
appear	O
in	O
the	O
long	B:C1517942
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
after	O
the	O
Ross	O
intervention	I:C0184661
,	O
but	O
the	O
factors	O
involved	O
and	O
its	O
clinical	O
implications	O
are	O
not	O
fully	O
known	O
.	O

Pulmonary	O
graft	I:C0034089
stenosis	I:C0034089
can	O
appear	O
in	O
the	O
long	O
-	I:C1517942
term	I:C1517942
follow	I:C1517942
-	I:C1517942
up	I:C1517942
after	O
the	O
Ross	B:C0184661
intervention	I:C0184661
,	O
but	O
the	O
factors	O
involved	O
and	O
its	O
clinical	O
implications	O
are	O
not	O
fully	O
known	O
.	O

To	O
describe	O
the	O
incidence	O
,	O
clinical	O
impact	O
and	O
predictors	O
of	O
homograft	B:C0450127
stenosis	O
and	O
reintervention	O
after	O
the	O
Ross	O
procedure	I:C0087111
in	O
a	O
prospective	O
series	O
in	O
a	O
tertiary	O
referral	I:C0587437
hospital	I:C0587437
.	O

To	O
describe	O
the	O
incidence	O
,	O
clinical	O
impact	O
and	O
predictors	O
of	O
homograft	O
stenosis	B:C1261287
and	O
reintervention	O
after	O
the	O
Ross	O
procedure	I:C0087111
in	O
a	O
prospective	O
series	O
in	O
a	O
tertiary	O
referral	I:C0587437
hospital	I:C0587437
.	O

To	O
describe	O
the	O
incidence	O
,	O
clinical	O
impact	O
and	O
predictors	O
of	O
homograft	O
stenosis	O
and	O
reintervention	B:C0184661
after	O
the	O
Ross	O
procedure	I:C0087111
in	O
a	O
prospective	O
series	O
in	O
a	O
tertiary	O
referral	I:C0587437
hospital	I:C0587437
.	O

To	O
describe	O
the	O
incidence	O
,	O
clinical	O
impact	O
and	O
predictors	O
of	O
homograft	O
stenosis	O
and	O
reintervention	O
after	O
the	O
Ross	B:C0087111
procedure	I:C0087111
in	O
a	O
prospective	O
series	O
in	O
a	O
tertiary	O
referral	I:C0587437
hospital	I:C0587437
.	O

To	O
describe	O
the	O
incidence	O
,	O
clinical	O
impact	O
and	O
predictors	O
of	O
homograft	O
stenosis	O
and	O
reintervention	O
after	O
the	O
Ross	O
procedure	I:C0087111
in	O
a	O
prospective	O
series	O
in	O
a	O
tertiary	B:C0587437
referral	I:C0587437
hospital	I:C0587437
.	O

From	O
1997	O
to	O
2009	O
,	O
107	O
patients	O
underwent	O
the	O
Ross	B:C0087111
procedure	I:C0087111
(	O
mean	O
age	O
:	O
30±11	O
years	O
;	O
69	O
%	O
men	O
;	O
21	O
aged	O
<	O
18	O
years	O
)	O
,	O
and	O
were	O
followed	O
for	O
echocardiographic	O
homograft	O
stenosis	O
(	O
peak	O
gradient	O
>	O
36	O
mmHg	O
)	O
and	O
surgical	O
or	O
percutaneous	O
homograft	O
reintervention	I:C0184661
.	O

From	O
1997	O
to	O
2009	O
,	O
107	O
patients	O
underwent	O
the	O
Ross	O
procedure	I:C0087111
(	O
mean	O
age	O
:	O
30±11	O
years	O
;	O
69	O
%	O
men	B:C0025266
;	O
21	O
aged	O
<	O
18	O
years	O
)	O
,	O
and	O
were	O
followed	O
for	O
echocardiographic	O
homograft	O
stenosis	O
(	O
peak	O
gradient	O
>	O
36	O
mmHg	O
)	O
and	O
surgical	O
or	O
percutaneous	O
homograft	O
reintervention	I:C0184661
.	O

From	O
1997	O
to	O
2009	O
,	O
107	O
patients	O
underwent	O
the	O
Ross	O
procedure	I:C0087111
(	O
mean	O
age	O
:	O
30±11	O
years	O
;	O
69	O
%	O
men	O
;	O
21	O
aged	O
<	O
18	O
years	O
)	O
,	O
and	O
were	O
followed	O
for	O
echocardiographic	B:C0013516
homograft	O
stenosis	O
(	O
peak	O
gradient	O
>	O
36	O
mmHg	O
)	O
and	O
surgical	O
or	O
percutaneous	O
homograft	O
reintervention	I:C0184661
.	O

From	O
1997	O
to	O
2009	O
,	O
107	O
patients	O
underwent	O
the	O
Ross	O
procedure	I:C0087111
(	O
mean	O
age	O
:	O
30±11	O
years	O
;	O
69	O
%	O
men	O
;	O
21	O
aged	O
<	O
18	O
years	O
)	O
,	O
and	O
were	O
followed	O
for	O
echocardiographic	O
homograft	B:C0450127
stenosis	O
(	O
peak	O
gradient	O
>	O
36	O
mmHg	O
)	O
and	O
surgical	O
or	O
percutaneous	O
homograft	O
reintervention	I:C0184661
.	O

From	O
1997	O
to	O
2009	O
,	O
107	O
patients	O
underwent	O
the	O
Ross	O
procedure	I:C0087111
(	O
mean	O
age	O
:	O
30±11	O
years	O
;	O
69	O
%	O
men	O
;	O
21	O
aged	O
<	O
18	O
years	O
)	O
,	O
and	O
were	O
followed	O
for	O
echocardiographic	O
homograft	O
stenosis	B:C1261287
(	O
peak	O
gradient	O
>	O
36	O
mmHg	O
)	O
and	O
surgical	O
or	O
percutaneous	O
homograft	O
reintervention	I:C0184661
.	O

From	O
1997	O
to	O
2009	O
,	O
107	O
patients	O
underwent	O
the	O
Ross	O
procedure	I:C0087111
(	O
mean	O
age	O
:	O
30±11	O
years	O
;	O
69	O
%	O
men	O
;	O
21	O
aged	O
<	O
18	O
years	O
)	O
,	O
and	O
were	O
followed	O
for	O
echocardiographic	O
homograft	O
stenosis	O
(	O
peak	O
gradient	O
>	O
36	O
mmHg	O
)	O
and	O
surgical	B:C0549433
or	O
percutaneous	O
homograft	O
reintervention	I:C0184661
.	O

From	O
1997	O
to	O
2009	O
,	O
107	O
patients	O
underwent	O
the	O
Ross	O
procedure	I:C0087111
(	O
mean	O
age	O
:	O
30±11	O
years	O
;	O
69	O
%	O
men	O
;	O
21	O
aged	O
<	O
18	O
years	O
)	O
,	O
and	O
were	O
followed	O
for	O
echocardiographic	O
homograft	O
stenosis	O
(	O
peak	O
gradient	O
>	O
36	O
mmHg	O
)	O
and	O
surgical	O
or	O
percutaneous	B:C0522523
homograft	O
reintervention	I:C0184661
.	O

From	O
1997	O
to	O
2009	O
,	O
107	O
patients	O
underwent	O
the	O
Ross	O
procedure	I:C0087111
(	O
mean	O
age	O
:	O
30±11	O
years	O
;	O
69	O
%	O
men	O
;	O
21	O
aged	O
<	O
18	O
years	O
)	O
,	O
and	O
were	O
followed	O
for	O
echocardiographic	O
homograft	O
stenosis	O
(	O
peak	O
gradient	O
>	O
36	O
mmHg	O
)	O
and	O
surgical	O
or	O
percutaneous	O
homograft	B:C0184661
reintervention	I:C0184661
.	O

After	O
15	O
years	O
of	O
follow	O
-	O
up	O
(	O
median	O
:	O
11	O
years	O
)	O
,	O
echocardiographic	B:C0013516
and	O
clinical	O
data	I:C1516606
were	O
available	O
in	O
91	O
(	O
85	O
%	O
)	O
and	O
104	O
(	O
98	O
%	O
)	O
patients	O
,	O
respectively	O
:	O
26/91	O
(	O
29	O
%	O
)	O
patients	O
developed	O
homograft	O
stenosis	O
;	O
10/104	O
(	O
10	O
%	O
)	O
patients	O
underwent	O
13	O
homograft	O
reintervention	I:C0184661
procedures	I:C0184661
(	O
three	O
patients	O
underwent	O
surgical	O
replacement	I:C4076286
,	O
three	O
received	O
a	O
percutaneous	O
pulmonary	O
valve	O
and	O
one	O
needed	O
stent	O
implantation	O
)	O
.	O

After	O
15	O
years	O
of	O
follow	O
-	O
up	O
(	O
median	O
:	O
11	O
years	O
)	O
,	O
echocardiographic	O
and	O
clinical	B:C1516606
data	I:C1516606
were	O
available	O
in	O
91	O
(	O
85	O
%	O
)	O
and	O
104	O
(	O
98	O
%	O
)	O
patients	O
,	O
respectively	O
:	O
26/91	O
(	O
29	O
%	O
)	O
patients	O
developed	O
homograft	O
stenosis	O
;	O
10/104	O
(	O
10	O
%	O
)	O
patients	O
underwent	O
13	O
homograft	O
reintervention	I:C0184661
procedures	I:C0184661
(	O
three	O
patients	O
underwent	O
surgical	O
replacement	I:C4076286
,	O
three	O
received	O
a	O
percutaneous	O
pulmonary	O
valve	O
and	O
one	O
needed	O
stent	O
implantation	O
)	O
.	O

After	O
15	O
years	O
of	O
follow	O
-	O
up	O
(	O
median	O
:	O
11	O
years	O
)	O
,	O
echocardiographic	O
and	O
clinical	O
data	I:C1516606
were	O
available	O
in	O
91	O
(	O
85	O
%	O
)	O
and	O
104	O
(	O
98	O
%	O
)	O
patients	O
,	O
respectively	O
:	O
26/91	O
(	O
29	O
%	O
)	O
patients	O
developed	O
homograft	B:C0450127
stenosis	O
;	O
10/104	O
(	O
10	O
%	O
)	O
patients	O
underwent	O
13	O
homograft	O
reintervention	I:C0184661
procedures	I:C0184661
(	O
three	O
patients	O
underwent	O
surgical	O
replacement	I:C4076286
,	O
three	O
received	O
a	O
percutaneous	O
pulmonary	O
valve	O
and	O
one	O
needed	O
stent	O
implantation	O
)	O
.	O

After	O
15	O
years	O
of	O
follow	O
-	O
up	O
(	O
median	O
:	O
11	O
years	O
)	O
,	O
echocardiographic	O
and	O
clinical	O
data	I:C1516606
were	O
available	O
in	O
91	O
(	O
85	O
%	O
)	O
and	O
104	O
(	O
98	O
%	O
)	O
patients	O
,	O
respectively	O
:	O
26/91	O
(	O
29	O
%	O
)	O
patients	O
developed	O
homograft	O
stenosis	B:C1261287
;	O
10/104	O
(	O
10	O
%	O
)	O
patients	O
underwent	O
13	O
homograft	O
reintervention	I:C0184661
procedures	I:C0184661
(	O
three	O
patients	O
underwent	O
surgical	O
replacement	I:C4076286
,	O
three	O
received	O
a	O
percutaneous	O
pulmonary	O
valve	O
and	O
one	O
needed	O
stent	O
implantation	O
)	O
.	O

After	O
15	O
years	O
of	O
follow	O
-	O
up	O
(	O
median	O
:	O
11	O
years	O
)	O
,	O
echocardiographic	O
and	O
clinical	O
data	I:C1516606
were	O
available	O
in	O
91	O
(	O
85	O
%	O
)	O
and	O
104	O
(	O
98	O
%	O
)	O
patients	O
,	O
respectively	O
:	O
26/91	O
(	O
29	O
%	O
)	O
patients	O
developed	O
homograft	O
stenosis	O
;	O
10/104	O
(	O
10	O
%	O
)	O
patients	O
underwent	O
13	O
homograft	B:C0184661
reintervention	I:C0184661
procedures	I:C0184661
(	O
three	O
patients	O
underwent	O
surgical	O
replacement	I:C4076286
,	O
three	O
received	O
a	O
percutaneous	O
pulmonary	O
valve	O
and	O
one	O
needed	O
stent	O
implantation	O
)	O
.	O

After	O
15	O
years	O
of	O
follow	O
-	O
up	O
(	O
median	O
:	O
11	O
years	O
)	O
,	O
echocardiographic	O
and	O
clinical	O
data	I:C1516606
were	O
available	O
in	O
91	O
(	O
85	O
%	O
)	O
and	O
104	O
(	O
98	O
%	O
)	O
patients	O
,	O
respectively	O
:	O
26/91	O
(	O
29	O
%	O
)	O
patients	O
developed	O
homograft	O
stenosis	O
;	O
10/104	O
(	O
10	O
%	O
)	O
patients	O
underwent	O
13	O
homograft	O
reintervention	I:C0184661
procedures	I:C0184661
(	O
three	O
patients	O
underwent	O
surgical	B:C4076286
replacement	I:C4076286
,	O
three	O
received	O
a	O
percutaneous	O
pulmonary	O
valve	O
and	O
one	O
needed	O
stent	O
implantation	O
)	O
.	O

After	O
15	O
years	O
of	O
follow	O
-	O
up	O
(	O
median	O
:	O
11	O
years	O
)	O
,	O
echocardiographic	O
and	O
clinical	O
data	I:C1516606
were	O
available	O
in	O
91	O
(	O
85	O
%	O
)	O
and	O
104	O
(	O
98	O
%	O
)	O
patients	O
,	O
respectively	O
:	O
26/91	O
(	O
29	O
%	O
)	O
patients	O
developed	O
homograft	O
stenosis	O
;	O
10/104	O
(	O
10	O
%	O
)	O
patients	O
underwent	O
13	O
homograft	O
reintervention	I:C0184661
procedures	I:C0184661
(	O
three	O
patients	O
underwent	O
surgical	O
replacement	I:C4076286
,	O
three	O
received	O
a	O
percutaneous	O
pulmonary	O
valve	O
and	O
one	O
needed	O
stent	B:C0038257
implantation	O
)	O
.	O

After	O
15	O
years	O
of	O
follow	O
-	O
up	O
(	O
median	O
:	O
11	O
years	O
)	O
,	O
echocardiographic	O
and	O
clinical	O
data	I:C1516606
were	O
available	O
in	O
91	O
(	O
85	O
%	O
)	O
and	O
104	O
(	O
98	O
%	O
)	O
patients	O
,	O
respectively	O
:	O
26/91	O
(	O
29	O
%	O
)	O
patients	O
developed	O
homograft	O
stenosis	O
;	O
10/104	O
(	O
10	O
%	O
)	O
patients	O
underwent	O
13	O
homograft	O
reintervention	I:C0184661
procedures	I:C0184661
(	O
three	O
patients	O
underwent	O
surgical	O
replacement	I:C4076286
,	O
three	O
received	O
a	O
percutaneous	O
pulmonary	O
valve	O
and	O
one	O
needed	O
stent	O
implantation	B:C0021107
)	O
.	O

The	O
other	O
three	O
patients	O
underwent	O
two	O
consecutive	O
procedures	O
in	O
follow	O
-	O
up	O
;	O
one	O
died	B:C0011065
because	O
of	O
a	O
procedure	O
-	O
related	O
myocardial	O
infarction	I:C0027051
.	O

The	O
other	O
three	O
patients	O
underwent	O
two	O
consecutive	O
procedures	O
in	O
follow	O
-	O
up	O
;	O
one	O
died	O
because	O
of	O
a	O
procedure	O
-	O
related	O
myocardial	B:C0027051
infarction	I:C0027051
.	O

Rates	O
of	O
survival	O
free	O
from	O
homograft	B:C0450127
stenosis	O
and	O
reintervention	O
at	O
1	O
,	O
5	O
and	O
10	O
years	O
were	O
96	O
%	O
,	O
82	O
%	O
and	O
75	O
%	O
and	O
99	O
%	O
,	O
94	O
%	O
and	O
91	O
%	O
,	O
respectively	O
.	O

Rates	O
of	O
survival	O
free	O
from	O
homograft	O
stenosis	B:C1261287
and	O
reintervention	O
at	O
1	O
,	O
5	O
and	O
10	O
years	O
were	O
96	O
%	O
,	O
82	O
%	O
and	O
75	O
%	O
and	O
99	O
%	O
,	O
94	O
%	O
and	O
91	O
%	O
,	O
respectively	O
.	O

Rates	O
of	O
survival	O
free	O
from	O
homograft	O
stenosis	O
and	O
reintervention	B:C0184661
at	O
1	O
,	O
5	O
and	O
10	O
years	O
were	O
96	O
%	O
,	O
82	O
%	O
and	O
75	O
%	O
and	O
99	O
%	O
,	O
94	O
%	O
and	O
91	O
%	O
,	O
respectively	O
.	O

Paediatric	O
patients	O
had	O
worse	O
survival	O
free	O
from	O
homograft	B:C0450127
stenosis	O
(	O
hazard	O
ratio	O
[	O
HR	O
]	O
3.50	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
:	O
1.56-7.90	O
;	O
P=0.002	O
)	O
,	O
although	O
there	O
were	O
no	O
significant	O
differences	O
regarding	O
reintervention	O
(	O
HR	O
:	O
2.01	O
,	O
95	O
%	O
CI	O
:	O
0.52-7.78	O
;	O
P=0.31	O
)	O
.	O

Paediatric	O
patients	O
had	O
worse	O
survival	O
free	O
from	O
homograft	O
stenosis	B:C1261287
(	O
hazard	O
ratio	O
[	O
HR	O
]	O
3.50	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
:	O
1.56-7.90	O
;	O
P=0.002	O
)	O
,	O
although	O
there	O
were	O
no	O
significant	O
differences	O
regarding	O
reintervention	O
(	O
HR	O
:	O
2.01	O
,	O
95	O
%	O
CI	O
:	O
0.52-7.78	O
;	O
P=0.31	O
)	O
.	O

Paediatric	O
patients	O
had	O
worse	O
survival	O
free	O
from	O
homograft	O
stenosis	O
(	O
hazard	O
ratio	O
[	O
HR	O
]	O
3.50	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
:	O
1.56-7.90	O
;	O
P=0.002	O
)	O
,	O
although	O
there	O
were	O
no	O
significant	O
differences	O
regarding	O
reintervention	B:C0184661
(	O
HR	O
:	O
2.01	O
,	O
95	O
%	O
CI	O
:	O
0.52-7.78	O
;	O
P=0.31	O
)	O
.	O

Younger	O
age	O
of	O
homograft	B:C0013018
donor	I:C0013018
was	O
also	O
a	O
stenosis	O
predictor	O
(	O
HR	O
:	O
0.97	O
,	O
95	O
%	O
CI	O
:	O
0.94-0.99	O
;	O
P=0.046	O
)	O
.	O

Younger	O
age	O
of	O
homograft	O
donor	I:C0013018
was	O
also	O
a	O
stenosis	B:C1261287
predictor	O
(	O
HR	O
:	O
0.97	O
,	O
95	O
%	O
CI	O
:	O
0.94-0.99	O
;	O
P=0.046	O
)	O
.	O

The	O
probabilities	O
of	O
homograft	B:C0450127
stenosis	O
and	O
reintervention	O
10	O
years	O
after	O
the	O
Ross	O
procedure	I:C0087111
were	O
29	O
%	O
and	O
10	O
%	O
,	O
respectively	O
;	O
only	O
one	O
patient	O
had	O
a	O
reintervention	O
-	O
related	O
death	O
.	O

The	O
probabilities	O
of	O
homograft	O
stenosis	B:C1261287
and	O
reintervention	O
10	O
years	O
after	O
the	O
Ross	O
procedure	I:C0087111
were	O
29	O
%	O
and	O
10	O
%	O
,	O
respectively	O
;	O
only	O
one	O
patient	O
had	O
a	O
reintervention	O
-	O
related	O
death	O
.	O

The	O
probabilities	O
of	O
homograft	O
stenosis	O
and	O
reintervention	B:C0184661
10	O
years	O
after	O
the	O
Ross	O
procedure	I:C0087111
were	O
29	O
%	O
and	O
10	O
%	O
,	O
respectively	O
;	O
only	O
one	O
patient	O
had	O
a	O
reintervention	O
-	O
related	O
death	O
.	O

The	O
probabilities	O
of	O
homograft	O
stenosis	O
and	O
reintervention	O
10	O
years	O
after	O
the	O
Ross	B:C0087111
procedure	I:C0087111
were	O
29	O
%	O
and	O
10	O
%	O
,	O
respectively	O
;	O
only	O
one	O
patient	O
had	O
a	O
reintervention	O
-	O
related	O
death	O
.	O

The	O
probabilities	O
of	O
homograft	O
stenosis	O
and	O
reintervention	O
10	O
years	O
after	O
the	O
Ross	O
procedure	I:C0087111
were	O
29	O
%	O
and	O
10	O
%	O
,	O
respectively	O
;	O
only	O
one	O
patient	O
had	O
a	O
reintervention	B:C0184661
-	O
related	O
death	O
.	O

The	O
probabilities	O
of	O
homograft	O
stenosis	O
and	O
reintervention	O
10	O
years	O
after	O
the	O
Ross	O
procedure	I:C0087111
were	O
29	O
%	O
and	O
10	O
%	O
,	O
respectively	O
;	O
only	O
one	O
patient	O
had	O
a	O
reintervention	O
-	O
related	O
death	B:C0011065
.	O

Younger	O
donor	B:C0013018
and	O
recipient	O
age	O
were	O
associated	O
with	O
a	O
higher	O
rate	O
of	O
stenosis	O
.	O

Younger	O
donor	O
and	O
recipient	B:C1709854
age	O
were	O
associated	O
with	O
a	O
higher	O
rate	O
of	O
stenosis	O
.	O

Younger	O
donor	O
and	O
recipient	O
age	O
were	O
associated	O
with	O
a	O
higher	O
rate	O
of	O
stenosis	B:C1261287
.	O

